A new auto-injecting pill might soon become a replacement for subcutaneous injection treatments. The idea for this so-called robotic pill came out of a research project around eight years ago from InCube Labs — a life sciences lab operated by Rani Therapeutics Chairman and CEO Mir Imran, who has degrees in electrical and biomedical engineering from Rutgers University.

Topics:  a   100%   domcontentloaded   ceo mir   university   synthetic   octreotide   next-gen   vcs   pr    verify   robotic pill   function   intestine   return   typeof   technology   side   funcsizeresponse   func   injections   needles   time   sciences   helps   develop   life   injecting   origin   effects   drug   investors   biology   
BING NEWS:
  • RANI Rani Therapeutics Holdings, Inc.
    Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States.
    04/12/2024 - 5:00 am | View Link
  • RANI: 2023 Results
    Rani Therapeutics Holdings ... delivering the biologic with its ingestible robotic RaniPill (RP). Bioavailability of 84% relative to subcutaneous injection was achieved in the study and the ...
    03/21/2024 - 4:57 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News